Insurance Code § 1369.654: PROHIBITION ON MULTIPLE PRIOR AUTHORIZATIONS
1 bill in the 90th Legislature would change this section
- HB 642 amends this section
Part of Insurance Code Chapter 1369, with every bill that changes it.
Bills are matched to sections automatically from their text and can be missed, for example when a bill changes a whole chapter at once or renumbers sections. No bill listed here does not mean no bill changes this section.
Current law
Sec. 1369.654. PROHIBITION ON MULTIPLE PRIOR AUTHORIZATIONS. (a) A health benefit plan issuer that provides prescription drug benefits may not require an enrollee to receive more than one prior authorization annually of the prescription drug benefit for a prescription drug prescribed to treat an autoimmune disease, hemophilia, or Von Willebrand disease.
(b) This section does not apply to:
(1) opioids, benzodiazepines, barbiturates, or carisoprodol;
(2) prescription drugs that have a typical treatment period of less than 12 months;
(3) drugs that:
(A) have a boxed warning assigned by the United States Food and Drug Administration for use; and
(B) must have specific provider assessment; or
(4) the use of a drug approved for use by the United States Food and Drug Administration in a manner other than the approved use.
Added by Acts 2023, 88th Leg., R.S., Ch. 669 (H.B. 755), Sec. 1, eff. September 1, 2023.
SUBCHAPTER Q. CLINICIAN-ADMINISTERED DRUGS
Links
- This chapter as it stands now, Markdown copy of the Texas Legislative Council's statute files
- Official text on statutes.capitol.texas.gov
- RSS feed of actions on these bills
Texas Bill Atlas is an independent research tool, not an official state website.